TARDBP and amyotrophic lateral sclerosis: We now show that C‐terminal TDP‐43 phosphorylation as detected on ALS/FTD inclusions has a similar inhibitory effect on TDP‐43 aggregation, underscoring the idea that aberrant PTMs detected on pathological inclusions may not necessarily all be drivers of protein aggregation, but could also have protective, anti‐aggregation effects that are later‐on overruled by other pathogenic mechanisms.